Xi'an Jiaotong University

TUESDAY, July 23, 2024 -- Greater adherence to a Mediterranean diet is associated with lower odds of depression in individuals with rheumatoid arthritis, according to a study published online July 5 in the Journal of Health, Population and Nutrition . Liya Ma, from Honghui Hospital at Xi’an Jiaotong University in China, and colleagues explored the association between adherence to a Mediterranean diet and depression in patients with rheumatoid arthritis. Analysis included 1,148 patients with rheumatoid arthritis (aged ≥20 years), for whom 24-hour dietary recall interview data were available. The researchers found that 25.26 percent of participants had depression. In adjusted analysis, high adherence to a Mediterranean diet was associated with the lower odds of depression (odds ratio, 0.53). Higher consumption of vegetables (odds ratio, 0.54) and cereals (odds ratio, 0.63) drove this decrease in the odds of depression. "In conclusion, we found that greater adherence to a Mediterranean diet was associated with the lower odds of depression in rheumatoid arthritis patients. Thus, our results provide evidence that greater adherence to Mediterranean diet may improve mental health in adults," the authors write. "To elucidate whether true causal associations exist between diet and depression, further more rigorous cohort studies are needed." Abstract/Full Text Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

THURSDAY, June 6, 2024 -- There is a positive correlation between diet-induced inflammation and a heart failure biomarker, according to a study published online June 5 in PLOS ONE . Teng-Chi Ma, from the First Affiliated Hospital of Xi'an Jiaotong University in China, and colleagues used data from the National Health and Nutrition Examination Survey (1999 to 2004; 10,766 individuals) to investigate the association between diet-induced inflammation (measured by the Dietary Inflammatory Index [DII]) and heart failure (measured by N-terminal pro B-type natriuretic peptide [NT-proBNP]). The researchers found that in individuals without heart failure, a unit increase in the DII was significantly associated with an increase in NT-proBNP levels when adjusting for demographic factors (8.57 pg/mL) and with further adjustments for health variables (5.54 pg/mL). For individuals with a history of heart failure, there was a trend toward higher NT-proBNP levels in the second and third DII quartile versus the lowest quartile (717.06 pg/mL and 855.49 pg/mL, respectively). There were also significant interactions by age (younger than 50 years: β = 3.63; 50 to 75 years: β = 18.4; 75 years and older: β = 56.09), gender (men: β = 17.82; women: β = 7.43), hypertension (β = 25.73), and diabetes (β = 38.94). “This study identified a positive correlation between the DII and NT-proBNP levels, suggesting a robust link between pro-inflammatory diets and increased heart failure biomarkers, with implications for dietary modifications in cardiovascular risk management,” conclude the authors. Abstract/Full Text Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

BISHKEK, Kyrgyzstan, April 3, 2024 /PRNewswire/ -- The International Medical Congress of the SCO countries was held on 27-29 March in Bishkek, Kyrgyzstan, under the theme "Innovations and technologies in the development of cardiology and non-communicable diseases in the countries of the Shanghai Cooperation Organization". Alymkadyr Beishenaliev, Minister of Health of the Kyrgyz Republic, Janesh Kane, Deputy Secretary General of the SCO, and 400 medical professionals, academicians and world-renowned scientists attended the congress. Tianlong Science and Technology was invited to attend and deliver a speech at the Congress, showcasing and discussing its latest achievements and innovations in the field of personalized medicine with top experts from around the world. Continue Reading Professor Kou Spoke at the International Medical Congress of SCO Countries Dr. Wu Spoke at the International Conference in Kyrgyzstan Tianlong's personalized medication solution At this congress, Tianlong invited Professor Kou Huijuan from the Department of Cardiology of the Second Affiliated Hospital of Xi'an Jiaotong University to give a speech. Professor Kou discussed the accurate treatment and current progress of hypertension diagnosis and treatment in China, as well as a series of clinical cases, and also introduced Tianlong's personalized medication solution for hypertension, which can detect seven gene mutations in hypertension medication and guide five types of hypertension medication. Professor Kou introduced that "Personalized medication is a new medical model that can determine the dosage and type of medication for each patient based on genetic differences", which provided valuable inspiration to the participants. Tianlong was also invited to join in a series of conferences and exchanges in Kyrgyzstan. At an international conference on "Topical issues of laboratory medicine", Jessica Wu(PhD of Molecular Biology) from Tianlong's Overseas Marketing Dept, delivered a speech about "LigSeq Reagent Kit - Tianlong's personalized medication solutions". During the presentation, Dr. Wu discussed the significance of personalized medication and shared the latest research and application cases. She introduced that "Tianlong's personalized medication solution can detect genes related to the effects of commonly used drugs for diseases, providing guidance for clinical treatment." The presentation has generated widespread interest and discussion among the attending experts. Tianlong's personalized medicine solutions, including a series of detection instruments and reagents, can detect genes related to the effects of commonly used drugs for assisted reproduction, endocrine drugs, as well as cardiovascular, digestive, psychiatric, rheumatic immunity, oncology and other diseases, providing guidance for clinical treatment. It has the advantages of rapid detection, accurate results, comprehensive report and user-friendliness. Tianlong's participation in the medical conferences facilitated international exchange and cooperation in the medical field. In the future, Tianlong will continue its commitment to scientific research, innovation and technological development for the global progress of medicine and healthcare. About Tianlong Tianlong is an innovative high-tech company specializing in genetic detection and molecular diagnostic products in China. Since its foundation in 1997, Tianlong has devoted itself to providing integrated PCR lab solutions for professionals worldwide. For more information, please visit Tianlong's official website and its LinkedIn, Facebook, and Twitter pages. For product or corporate information inquiries may be directed to [email protected]. SOURCE Tianlong Science and Technology